Gufic Biosciences Limited - Balance (Quarterly)

Gufic Biosciences Limited
IN ˙ NSEI
325,45 ₹ ↑7,45 (2,34%)
2026-05-27
DEL PRIS
Balance (Quarterly)

Gufic Biosciences Limited Balance viser kontosaldi for virksomheden på tidspunkter. Balancedata inkluderer aktiver, omsætningsaktiver, anlægsaktiver, materielle anlægsaktiver (PPE), inventar, immaterielle aktiver, passiver, kortfristede forpligtelser, gæld, kapitalleasingforpligtelser, almindelige aktier, overført overskud, egne aktier og egenkapital.

Alle tal er gange 1,000,000.00 undtagen pr. andel enheder.

2021
09-30
2022
03-31
2023
03-31
2023
09-30
2024
03-31
2024
09-30
2025
03-31
2025
09-30
2026
03-31
Kontanter 730 116 286 163 11 194 157 881 762
Ændring (%) -84,09 146,40 -42,95 -93,03 1.606,15 -18,93 460,18 -13,47
Aktiver Nuværende 3.643 3.208 4.641 5.114 6.005 5.784 6.245 7.272 8.021
Ændring (%) -11,96 44,69 10,19 17,41 -3,68 7,98 16,44 10,30
Aktiver 5.120 5.214 8.612 9.694 10.925 11.047 11.694 12.711 13.424
Ændring (%) 1,83 65,16 12,57 12,70 1,11 5,86 8,70 5,61
Forpligtelser 2.838 2.523 5.134 5.787 5.600 5.305 5.683 6.399 6.774
Ændring (%) -11,09 103,48 12,73 -3,24 -5,27 7,12 12,61 5,85
Egenkapital 2.283 2.691 3.478 3.907 5.326 5.742 6.011 6.312 6.650
Ændring (%) 17,90 29,24 12,32 36,32 7,81 4,68 5,01 5,36
Passiver og Aktiekapital 5.120 5.214 8.612 9.694 10.925 11.047 11.694 12.711 13.424
Ændring (%) 1,83 65,16 12,57 12,70 1,11 5,86 8,70 5,61

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
IN:509079 356,55 ₹
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista